极品新婚夜少妇真紧,亚洲精品一区二区三区中文字幕 ,久久久久人妻精品一区三寸蜜桃,日韩人妻无码一区二区三区

產(chǎn)品資料

Leucine Rich Repeat Kinase 2 (LRRK2), Recombinant Protein

如果您對該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱: Leucine Rich Repeat Kinase 2 (LRRK2), Recombinant Protein
產(chǎn)品型號:
產(chǎn)品展商: 其他品牌
產(chǎn)品文檔: 無相關(guān)文檔

簡單介紹

Leucine Rich Repeat Kinase 2 (LRRK2), Recombinant Protein


Leucine Rich Repeat Kinase 2 (LRRK2), Recombinant Protein  的詳細(xì)介紹
Product Name

Leucine Rich Repeat Kinase 2 (LRRK2), Recombinant Protein

Popular Item
Full Product Name

Recombinant Leucine Rich Repeat Kinase 2 (LRRK2)

Product Gene Name

LRRK2 recombinant protein

[Similar Products]
Matching Pairs
Biotin Conjugated Antibody: Leucine Rich Repeat Kinase 2 (LRRK2) (MBS2003244)
Immunogen: Leucine Rich Repeat Kinase 2 (LRRK2) (MBS2012043)
Matching Pairs
Unconjugated Antibody: Leucine Rich Repeat Kinase 2 (LRRK2) (MBS2005994)
Immunogen: Leucine Rich Repeat Kinase 2 (LRRK2) (MBS2012043)
Matching Pairs
APC-CY7 Conjugated Antibody: Leucine Rich Repeat Kinase 2 (LRRK2) (MBS2080194)
Immunogen: Leucine Rich Repeat Kinase 2 (LRRK2) (MBS2012043)
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
TOP
MBS2012043 Technical Datasheet
Technical Datasheet PDF
Chromosome Location
Chromosome: 12; NC_000012.11 (40618813..40763087). Location: 12q12
OMIM
168600
3D Structure
ModBase 3D Structure for Q5S007
Host
E.coli
Purity/Purification
> 97%
Concentration
Original Concentration: 200 ug/mL (lot specific)
Organism Species
Homo sapiens (Human)
Source
Prokaryotic expression
Residues
Phe1479~Pro1729
Tags
N-terminal His Tag
Subcellular Location
Membrane, Mitochondrion, Cytoplasm
Traits
Freeze-dried powder
Buffer formulation
10mM PBS, pH7.4, containing 1mM DTT, 5% trehalose, 0.01% sarcosyl and Proclin300.
Predicted isoelectric point
7.8
Predicted Molecular Mass
30.8kDa
Accurate Molecular Mass
30kDa as determined by SDS-PAGE reducing conditions.
USAGE
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
Preparation and Storage
Storage: Avoid repeated freeze/thaw cycles.
Store at 2-8oC for one month.
Aliquot and store at -80oC for 12 months.

Stability Test: The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
ISO Certification
Manufactured in an ISO 9001:2008 and ISO 13485:2003 Certified Laboratory.
Supply Chain Verification
Manufactured in a lab with traceable raw materials. Bulk orders can typically be prepared to the customera??s specifications, please inquire.
Other Notes
Small volumes of LRRK2 recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
TOP
Applications Tested/Suitable for LRRK2 recombinant protein
Positive Control; Immunogen; SDS-PAGE; WB.

(May be suitable for use in other assays to be determined by the end user.)

SDS-Page of LRRK2 recombinant protein
LRRK2 recombinant protein SDS-Page image
TOP
NCBI/Uniprot data below describe general gene information for LRRK2. It may not necessarily be applicable to this product.
NCBI GI #
171846278
NCBI GeneID
120892
NCBI Accession #
NP_940980.3 [Other Products]
NCBI GenBank Nucleotide #
NM_198578.3 [Other Products]
UniProt Primary Accession #
Q5S007 [Other Products]
UniProt Secondary Accession #
Q6ZS50; Q8NCX9; A6NJU2[Other Products]
UniProt Related Accession #
Q5S007[Other Products]
Molecular Weight
31.0kDa
TOP
NCBI Official Full Name
leucine-rich repeat serine/threonine-protein kinase 2
NCBI Official Synonym Full Names
leucine-rich repeat kinase 2
NCBI Official Symbol
LRRK2??[Similar Products]
NCBI Official Synonym Symbols
PARK8; RIPK7; ROCO2; AURA17; DARDARIN
??[Similar Products]
NCBI Protein Information
leucine-rich repeat serine/threonine-protein kinase 2; augmented in rheumatoid arthritis 17
UniProt Protein Name
Leucine-rich repeat serine/threonine-protein kinase 2
UniProt Synonym Protein Names
Dardarin
Protein Family
Leucine-rich repeat serine/threonine-protein kinase
UniProt Gene Name
LRRK2??[Similar Products]
UniProt Synonym Gene Names
PARK8??[Similar Products]
UniProt Entry Name
LRRK2_HUMAN
TOP
NCBI Summary for LRRK2
This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008]
TOP
UniProt Comments for LRRK2
LRRK2: a large multidomain protein kinase with a TKL-type kinase domain, multiple protein-protein interaction domains and a mitochondrial Rho domain (MIRO). May play a role in the etiology of Parkinson disease. May also have GTPase activity. Positively regulates autophagy through a calcium-dependent activation of the CaMKK/AMPK signaling pathway. The process involves activation of nicotinic acid adenine dinucleotide phosphate (NAADP) receptors, increase in lysosomal pH, and calcium release from lysosomes. Interacts with PARK2, PRDX3 and TPCN2. Expressed throughout the ***** brain, but at a lower level than in heart and liver. Expressed in the cerebellum, cerebral cortex, medulla, spinal cord occipital pole, frontal lobe, temporal lobe and putamen. Expression is particularly high in brain dopaminoceptive areas. Defects in LRRK2 are the cause of Parkinson disease type 8 (PARK8). A slowly progressive neurodegenerative disorder characterized by bradykinesia, rigidity, resting tremor, postural instability, neuronal loss in the substantia nigra, and the presence of neurofibrillary MAPT (tau)-positive and Lewy bodies in some patients.

Protein type: Protein kinase, TKL; Protein kinase, Ser/Thr (non-receptor); Kinase, protein; EC 2.7.11.1; TKL group; LRRK family

Chromosomal Location of Human Ortholog: 12q12

Cellular Component: dendrite cytoplasm; Golgi apparatus; extracellular space; mitochondrion; lysosome; dendrite; terminal button; inclusion body; trans-Golgi network; cytosol; lipid raft; mitochondrial outer membrane; cell soma; mitochondrial matrix; mitochondrial inner membrane; cytoplasm; cytoplasmic vesicle; endosome; neuron projection; synaptic vesicle membrane; endoplasmic reticulum; perikaryon; axon; mitochondrial membrane; plasma membrane; cell junction

Molecular Function: tubulin binding; GTPase activity; identical protein binding; GTP-dependent protein kinase activity; clathrin binding; protein homodimerization activity; Rho GTPase binding; GTP binding; actin binding; GTPase activator activity; protein kinase activity; MAP kinase kinase activity; protein serine/threonine kinase activity; SNARE binding; protein binding; protein kinase A binding; syntaxin-1 binding; kinase activity; glycoprotein binding; ATP binding

Biological Process: regulation of synaptic transmission, glutamatergic; positive regulation of protein binding; activation of MAPKK activity; activation of MAPK activity; protein amino acid autophosphorylation; regulation of neuron maturation; determination of ***** life span; protein amino acid phosphorylation; positive regulation of MAP kinase activity; tangential migration from the subventricular zone to the olfactory bulb; negative regulation of protein amino acid phosphorylation; regulation of dopamine receptor signaling pathway; small GTPase mediated signal transduction; regulation of mitochondrial depolarization; negative regulation of protein binding; neuromuscular junction development; positive regulation of autophagy; positive regulation of dopamine receptor signaling pathway; olfactory bulb development; MAPKKK cascade; peptidyl-threonine phosphorylation; endocytosis; regulation of locomotion; peptidyl-serine phosphorylation; positive regulation of programmed cell death; regulation of membrane potential; positive regulation of protein ubiquitination; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; intracellular distribution of mitochondria; autophagy; positive regulation of protein amino acid phosphorylation; response to oxidative stress; regulation of excitatory postsynaptic membrane potential; neurite morphogenesis; positive regulation of GTPase activity

Disease: Parkinson Disease 8, Autosomal Dominant
Research Articles on LRRK2
1. The findings of this study suggested that 22q11.2 deletions represent a novel genetic risk factor for early-onset PD with variable neuropathological presentation reminiscent of LRRK2-associated PD neuropathology
TOP
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
TOP
TOP
產(chǎn)品留言
標(biāo)題
聯(lián)系人
聯(lián)系電話
內(nèi)容
驗(yàn)證碼
點(diǎn)擊換一張
注:1.可以使用快捷鍵Alt+S或Ctrl+Enter發(fā)送信息!
2.如有必要,請您留下您的詳細(xì)聯(lián)系方式!
相關(guān)產(chǎn)品
PDGF-AA, ELISA Kit
PDGF-AA, ELISA Kit
PDGF-AA, ELISA Kit
PDGF-AA, ELISA Kit
PDGF-AA, ELISA Kit
PDGF-AA, ELISA Kit
PDGF-AA, ELISA Kit
Microphthalmia Associated Transcription Factor (MITF), ELISA Kit
microphthalmia-associated transcription factor, Polyclonal Antibody
CYP1B1, Polyclonal Antibody
CYP1B1, Polyclonal Antibody
CYP1B1, Blocking Peptide
CYP1B1, Polyclonal Antibody
CYP1B1, Polyclonal Antibody
CYP1B1, Polyclonal Antibody
CYP1B1, Polyclonal Antibody
CYP1B1, Polyclonal Antibody
CYP1B1, Antibody
CYP1B1, Polyclonal Antibody
CYP1B1, Polyclonal Antibody
CYP1B1, cDNA Clone
CYP1B1, Antibody
Cytochrome P450 1B1, Antibody
Cytochrome P450 1B1, Polyclonal Antibody
Cytochrome P450 1B1, Polyclonal Antibody
Cytochrome P450 1B1, Antibody
Cytochrome P450 1B1, Antibody
Cytochrome P450 1B1 (CYP1B1), Polyclonal Antibody
Cytochrome P450 1B1 (CYP1B1), Polyclonal Antibody
Cytochrome P450 1B1 (CYP1B1), Polyclonal Antibody
Cytochrome P450 1B1 (CYP1B1), Polyclonal Antibody
Cytochrome P450 1B1 (CYP1B1), Polyclonal Antibody
Cytochrome P450 1B1 (CYP1B1), Polyclonal Antibody
Cytochrome P450 1B1 (CYP1B1), ELISA Kit
Cytochrome P450 1B1 (CYP1B1), ELISA Kit
Cytochrome P450 1B1 (CYP1B1), ELISA Kit
Cytochrome P450 1B1 (CYP1B1), ELISA Kit
Cytochrome P450 1B1 (CYP1B1), Antibody Pair Kit
Cytochrome P450 1B1 (CYP1B1), Active Protein
Cytochrome P450 1B1 (CYP1B1), Polyclonal Antibody
Cytochrome P450 1B1 (CYP1B1), RTU ELISA Kit
Cytochrome P450 1B1 (CYP1B1), Recombinant Protein
Optineurin, Polyclonal Antibody
AGPAT2, Polyclonal Antibody
AGPAT2, cDNA Clone
AGPAT2, cDNA Clone
AGPAT2, Polyclonal Antibody
AGPAT2, Polyclonal Antibody
AGPAT2, Blocking Peptide
AGPAT2, cDNA Clone

滬公網(wǎng)安備 31011202007343號